Cardiology

Knowing the Risks: Emergency Signs and Complications

At a Glance

With tricuspid stenosis, sudden severe breathlessness, chest pain, fainting, blue lips, coughing up blood, or signs of shock require emergency care. Rapid swelling, weight gain, reduced urination, or breathlessness when lying flat should prompt a call to cardiology; procedure risks vary by patient.

While living with tricuspid stenosis often involves managing chronic, stable symptoms, it is vital to know when a situation requires prompt attention. Likewise, understanding the serious risks of heart procedures helps you make an informed choice with your care team.

Recognizing Emergency “Red Flags” and When to Call

Most people with tricuspid stenosis experience a slow, predictable backup of fluid. However, certain symptoms indicate that the condition is worsening or a complication has occurred.

When to call emergency services (911):
Seek emergency medical evaluation immediately if you experience:

Refractory Shock or Severe Hypotension: Extreme weakness, confusion, cold or “clammy” skin, or fainting (syncope), which are signs that not enough blood is reaching your brain or organs ^[1]^[2]^[3]^[4].
Rapidly Worsening Breathlessness: A sudden, sharp increase in shortness of breath, severe palpitations, or chest pain ^[5]^[6].
Signs of a Blood Clot (Thrombus): Sudden chest pain, coughing up blood (hemoptysis), or sudden swelling and pain in the arm or neck, which can happen if a clot travels to the lungs ^[6]^[7].
New Hypoxemia: Blue lips or a sudden drop in your oxygen levels. (A low home pulse-oximeter reading can sometimes be inaccurate, but if it is accompanied by symptoms, seek urgent care) ^[8].

When to call your cardiology team the same day:
Rapidly increasing right-sided congestion may not require 911, but it needs prompt clinical advice. Call your team if you experience:

Rapidly increasing swelling (edema) in your legs or sudden abdominal distension ^[5]^[9].
Significant, sudden weight gain (e.g., above your personalized threshold).
A noticeable reduction in how much you urinate.
A new inability to lie flat without feeling breathless, or drastically worsening exercise tolerance.

Serious Risks of Interventions

Every heart procedure carries risks. For tricuspid stenosis, these risks are often influenced by how much damage has already occurred in your liver or kidneys due to years of fluid backup. Some teams use liver and kidney tests, along with a validated risk model (such as the MELD score), to help estimate surgical risk ^[10]^[11].

Important Note: The statistics below are illustrative ranges from large studies that commonly combine patients with severe tricuspid regurgitation, mixed valve disease, reoperations, and varied risk profiles. They do not predict your personal risk. Obtain your center-specific risk estimate from your surgeon.

Surgical Risks (Repair and Replacement)

Operative Mortality: In large mixed studies of tricuspid surgery, the risk of death during or shortly after the operation is approximately 8.4% for repair and 9.9% for replacement ^[12]^[13].
Acute Kidney Injury (AKI): Because the kidneys are sensitive to changes in blood flow during surgery, about 12% to 16% of patients in mixed cohorts may experience temporary or permanent kidney damage ^[12]^[14].
Permanent Pacemaker (PPM): Because the heart’s electrical system runs very close to the tricuspid valve, it can be damaged during surgery. In mixed cohorts, replacement carries a higher risk of needing a new pacemaker (about 21% to 24%) compared to repair (about 4% to 9%) ^[12]^[15].
Bleeding and Stroke: Bleeding requiring a transfusion occurs in about 7% of cases, while the risk of a stroke is generally low, estimated at roughly 1% to 1.5% ^[16]^[14].

Transcatheter Risks (Valve-in-Valve)

For those receiving a new valve through a tube (TViV), the risks are different:

Paravalvular Leak (PVL): This occurs if blood leaks around the outside of the new valve frame. While often mild, severe leaks can lead to further heart failure and may require a follow-up procedure ^[17]^[18].
Pacemaker Risk: Even in minimally invasive transcatheter procedures, the risk of needing a new pacemaker remains significant, occurring in approximately 8% to 17% of patients in historical registries ^[19]^[20].

Long-Term Monitoring: Thrombosis and Endocarditis

Once a new valve (biological or mechanical) is in place, you face two ongoing risks:

Valve Thrombosis: This is the formation of a blood clot on the valve leaflets, which can cause the valve to become narrowed again ^[1]^[21]. This is more common with replacements than repairs ^[14].
Infective Endocarditis: This is a serious infection of the heart valve ^[22]^[23]. Rates vary substantially based on the device, follow-up period, and patient population.

To manage these risks, your doctor will discuss preventive medications:

Anticoagulation: Mechanical valves require lifelong vitamin-K-antagonist anticoagulation (like warfarin). Native valves, surgical repairs, or bioprosthetic valves do not automatically require lifelong blood thinners, though they may be needed temporarily after surgery, or long-term if you have atrial fibrillation or another indication ^[23]^[24].
Antibiotics: Taking prophylactic antibiotics before certain dental procedures is limited to selected high-risk patients (which includes many with prosthetic valves), and is not routinely used before all medical procedures.

Always confirm your specific medication and dental-care plan with your cardiology and dental teams.

Common questions in this guide

Which symptoms mean I should call 911 for tricuspid stenosis?

Call 911 for sudden severe shortness of breath, chest pain, fainting, confusion, cold clammy skin, blue lips, coughing up blood, or sudden painful swelling in an arm or neck. These symptoms can signal shock, a blood clot, or worsening heart function and need emergency evaluation.

When should I contact my cardiology team urgently?

Contact your team the same day for rapidly worsening leg swelling or abdominal enlargement, sudden weight gain, much less urination, inability to lie flat because of breathlessness, or a major decline in exercise tolerance. Your team can help decide whether the change needs urgent assessment.

What complications can happen during tricuspid valve surgery?

Possible complications include death, kidney injury, bleeding, stroke, and the need for a permanent pacemaker. Published estimates come from mixed patient groups, so your surgeon should calculate a center-specific risk using your heart, liver, and kidney health.

Is a pacemaker more likely after tricuspid valve replacement?

A permanent pacemaker is generally more common after tricuspid valve replacement than after repair because the heart’s electrical system lies close to the valve. Transcatheter valve-in-valve procedures also carry a pacemaker risk, so ask your team for your center-specific estimate.

Can a replacement valve develop a clot or infection?

Yes. A clot can form on a replacement valve and narrow it again, and infective endocarditis is a serious infection of the valve. Follow-up, the correct blood-thinner plan, and dental-care guidance help manage these risks.

Will I need lifelong blood thinners after tricuspid valve treatment?

Mechanical valves generally require lifelong treatment with a vitamin-K-antagonist blood thinner such as warfarin. Repairs and biological valves do not automatically require lifelong blood thinners, although temporary or long-term treatment may be needed for another reason, such as atrial fibrillation.

Get notified when new evidence is published on tricuspid valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (24)

1
Ventricular Septal Defect as a Bail-out Shunt in Prosthetic Tricuspid Valve Obstruction.
Fowaz H, Adawi S, Aker A
Journal of cardiovascular echography 2026; (36(2)):202-204 doi:10.4103/jcecho.jcecho_151_25.
PMID: 42389410
2
Mechanical tricuspid balloon 'valvuloplasty' in a prohibitive risk patient with cardiogenic shock: a case report.
Hanna N, Carmona A, Crespo H, Cubeddu RJ
European heart journal. Case reports 2020; (4(3)):1-4 doi:10.1093/ehjcr/ytaa086.
PMID: 32617470
3
Hydatid cyst in the right ventricle leading to tricuspid stenosis and heart failure: a case report.
Hameed MS, Zaidi SRH, Saleem S, et al.
Journal of cardiothoracic surgery 2026; (21(1)).
PMID: 42001156
4
[Structural Deterioration of a Bovine Pericardial Valve in a Tricuspid Position 14 Years Postoperatively;Report of a Case].
Ota K, Tanaka K, Asano N, et al.
Kyobu geka. The Japanese journal of thoracic surgery 2018; (71(3)):199-203.
PMID: 29755074
5
Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.
Harjola VP, Mebazaa A, Čelutkienė J, et al.
European journal of heart failure 2016; (18(3)):226-41 doi:10.1002/ejhf.478.
PMID: 26995592
6
Severe tricuspid bioprosthetic valve stenosis as an unusual cause of pulmonary embolism: a case report.
Naser JA, Arghami A, Eleid MF, Pislaru SV
European heart journal. Case reports 2021; (5(5)):ytab169 doi:10.1093/ehjcr/ytab169.
PMID: 34124568
7
Bloody tricuspid stenosis: case report of an uncommon cause of haemoptysis.
Trombara F, Bergonti M, Toscano O, et al.
European heart journal. Case reports 2021; (5(2)):ytaa537 doi:10.1093/ehjcr/ytaa537.
PMID: 33598616
8
Fatal Platypnea-Orthodeoxia Syndrome After Transcatheter Tricuspid Valve Replacement: When HALT Reverses the Shunt.
Streukens SAF, Peeters FECM, Theunissen RALJ, et al.
JACC. Case reports 2026; (31(27)):108368 doi:10.1016/j.jaccas.2026.108368.
PMID: 42153924
9
Bioprosthetic tricuspid valve stenosis: a case series.
Hirata K, Tengan T, Wake M, et al.
European heart journal. Case reports 2019; (3(3)) doi:10.1093/ehjcr/ytz110.
PMID: 31367735
10
Cluster analysis of Model for End-stage Liver Disease and European System for Cardiac Operative Risk Evaluation for predicting operative mortality after concomitant tricuspid valve surgery.
Lim K, Au ACC, Hui MMH, et al.
JTCVS structural and endovascular 2024; (1-2()):100017 doi:10.1016/j.xjse.2024.100017.
PMID: 42305830
11
Tricuspid Regurgitation in Congestive "End-Organ" Failure: Outline of an Opportunity.
Farooq MU, Latib A, Jorde UP
Cardiology in review 2024; (32(1)):18-23 doi:10.1097/CRD.0000000000000455.
PMID: 35452428
12
Isolated surgical tricuspid repair versus replacement: meta-analysis of 15 069 patients.
Wang TKM, Griffin BP, Miyasaka R, et al.
Open heart 2020; (7(1)):e001227 doi:10.1136/openhrt-2019-001227.
PMID: 32206317
13
Contemporary practice patterns and outcomes of isolated tricuspid valve surgery in North America: systematic review with meta-analysis.
Lee T, Tavolacci SC, Boateng P, El-Eshmawi A
Annals of cardiothoracic surgery 2026; (15(3)):31 doi:10.21037/acs-2026-0132-tvd.
PMID: 42292586
14
A Systematic Review and Meta-Analysis of the Clinical Outcomes of Isolated Tricuspid Valve Surgery.
Chick W, Alkhalil M, Egred M, et al.
The American journal of cardiology 2023; (203()):414-426 doi:10.1016/j.amjcard.2023.07.006.
PMID: 37531685
15
Factors Associated With Permanent Pacemaker Placement After Tricuspid Valve Operations.
Zaheer S, Holmes SD, Rodriguez E, et al.
The Annals of thoracic surgery 2025; (119(2)):377-387 doi:10.1016/j.athoracsur.2024.09.042.
PMID: 39426556
16
Outcome of patients undergoing isolated tricuspid repair or replacement surgery.
Russo M, Di Mauro M, Saitto G, et al.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2022; (62(3)) doi:10.1093/ejcts/ezac230.
PMID: 35448903
17
Incidence, Clinical Implications, and Predictors of Paravalvular Leak Following Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry.
Scotti A, Latib A, Filtz A, et al.
JACC. Cardiovascular interventions 2026; (19(6)):680-693 doi:10.1016/j.jcin.2026.01.281.
PMID: 41881643
18
Transcatheter Valve-in-Ring Implantation for the Treatment of Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair.
Aboulhosn J, Cabalka AK, Levi DS, et al.
JACC. Cardiovascular interventions 2017; (10(1)):53-63 doi:10.1016/j.jcin.2016.10.036.
PMID: 28057286
19
Clinical Outcomes Following Transcatheter Tricuspid Valve Replacement - A Meta-Analysis.
Hatab T, Badwan O, Alkhatib R, et al.
Structural heart : the journal of the Heart Team 2025; (9(11)):100721 doi:10.1016/j.shj.2025.100721.
PMID: 41142382
20
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation.
Hahn RT, Makkar R, Thourani VH, et al.
The New England journal of medicine 2025; (392(2)):115-126 doi:10.1056/NEJMoa2401918.
PMID: 39475399
21
[Efficacies of tricuspid valve replacement versus repair for moderate-to-severe tricuspid regurgitation with right heart failure].
Fu J, Chen Q, Xu D, et al.
Zhonghua yi xue za zhi 2015; (95(18)):1396-400.
PMID: 26178357
22
Long-term outcomes of surgical repair versus replacement for tricuspid valve endocarditis - A meta-analysis of reconstructed time-to-event data.
Katsuyama E, Fukunaga C, Passos FS, et al.
International journal of cardiology. Heart & vasculature 2025; (60()):101782 doi:10.1016/j.ijcha.2025.101782.
PMID: 40918747
23
Mid-Term Valve-Related Outcomes After Transcatheter Tricuspid Valve-in-Valve or Valve-in-Ring Replacement.
McElhinney DB, Aboulhosn JA, Dvir D, et al.
Journal of the American College of Cardiology 2019; (73(2)):148-157 doi:10.1016/j.jacc.2018.10.051.
PMID: 30654886
24
Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly.
Taggart NW, Cabalka AK, Eicken A, et al.
The American journal of cardiology 2018; (121(2)):262-268 doi:10.1016/j.amjcard.2017.10.017.
PMID: 29153244

This page explains emergency warning signs, procedure risks, and follow-up concerns related to tricuspid stenosis for educational purposes; it does not replace medical advice. Ask your cardiology team about your personal risk and when to seek care.